Skip to main content
    M

    MiMedx Group Inc (MDXG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.69
    -0.14 (-2.90%)

    Market Cap: $685.89M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(24/37)
    Avg Surprise
    +3.54%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.01
    Range$-0.02 - $0.05
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.00+368.0%
    60d ago$-0.00+303.0%
    30d ago$0.010.0%
    7d ago$0.010.0%
    Current$0.01
    Revenue Consensus
    $70M
    Range$66M - $71M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.04 - $0.09
    3 analysts
    Revenue Consensus
    $71M
    Range$62M - $76M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$0.01---
    Jun 26
    Reported Jul 29
    		$-0.05$-0.03-66.67%Miss-150.0%
    Mar 26
    Reported Apr 29
    		$-0.05$-0.04-25.00%Miss-200.0%
    Dec 25
    Reported Feb 25
    		$0.14$0.09+50.70%Beat+100.0%
    Sep 25
    Reported Oct 29
    		$0.15$0.08+87.50%Beat+114.3%
    Jun 25
    Reported Jul 30
    		$0.10$0.06+66.67%Beat+25.0%
    Mar 25
    Reported Apr 30
    		$0.05$0.06-16.67%Miss-28.6%
    Dec 24
    Reported Feb 26
    		$0.07$0.07-6.67%Miss-78.1%
    Sep 24
    Reported Oct 30
    		$0.07$0.05+40.00%Beat+40.0%
    Jun 24
    Reported Jul 31
    		$0.08$0.08+0.00%Beat+1839.1%
    Mar 24
    Reported Apr 30
    		$0.07$0.04+75.00%Beat+333.3%
    Dec 23
    Reported Feb 28
    		$0.32$0.07+357.14%Beat+1700.0%
    Sep 23
    Reported Oct 30
    		$0.05$0.05+0.00%Beat+183.3%
    Jun 23
    Reported Aug 1
    		$-0.00N/A+84.67%Beat+94.2%
    Mar 23
    Reported May 2
    		$-0.03N/A+57.14%Beat+66.7%
    Dec 22
    Reported Feb 28
    		$-0.02$-0.04+50.00%Beat-300.0%
    Sep 22
    Reported Nov 2
    		$-0.06$-0.12+50.00%Beat-500.0%
    Jun 22
    Reported Aug 2
    		$-0.08$-0.08+0.00%Beat-60.0%
    Mar 22
    Reported May 3
    		$-0.09$-0.10+10.00%Beat+0.0%
    Dec 21
    Reported Feb 28
    		$0.01N/A+133.33%Beat+105.9%
    Sep 21
    Reported Nov 2
    		$-0.01N/A+85.71%Beat-103.7%
    Jun 21
    Reported Aug 3
    		$-0.05$-0.08+37.50%Beat-171.4%
    Mar 21
    Reported Apr 28
    		$-0.09N/A+52.63%Beat-12.5%
    Dec 20
    Reported Mar 8
    		$-0.17$-0.05-240.00%Miss-144.7%
    Sep 20
    Reported Nov 4
    		$0.27N/AN/ABeat+145.5%
    Jun 20
    Reported Jul 6
    		$0.07$0.12-41.67%Miss+143.8%
    Mar 20
    Reported Jun 30
    		$-0.08$0.00N/AMiss+33.3%
    Dec 19
    Reported Mar 17
    		$0.38$0.09+322.22%Beat+404.7%
    Sep 19
    Reported Oct 31
    		$0.11$0.15-26.67%Miss+133.2%
    Jun 19
    Reported Jul 31
    		$-0.16$0.14-214.29%Miss-1087.7%
    Mar 19
    Reported Apr 26
    		$-0.12$0.13-192.31%Miss-233.3%
    Dec 18
    Reported Feb 21
    		$-0.12$0.14-189.07%Miss-224.7%
    Sep 18
    Reported Oct 25
    		$-0.33$0.13-355.23%Miss-514.8%
    Jun 18
    Reported Jul 26
    		$0.02N/A-85.27%Miss-76.9%
    Mar 18
    Reported Apr 26
    		$0.09$0.09+0.00%Beat+28.6%
    Dec 17
    Reported Mar 31
    		$0.10$0.07+42.86%Beat+42.9%
    Sep 17
    Reported Oct 26
    		$0.08$0.08+0.00%Beat-
    Jun 17
    Reported Jul 26
    		$0.07$0.07+0.00%Beat-
    Mar 17
    Reported Apr 28
    		$0.07$0.07+0.00%Beat-
    Dec 16
    Reported Feb 23
    		$0.07$0.08-12.50%Miss-

    Key Metrics

    Valuation
    P/E Ratio24.68EV/EBITDA28.98x
    Price/FCF15.58xFCF Yield6.42%
    Profitability
    Profit Margin1.76%Operating Margin-28.70%
    ROE2.88%ROIC2.28%
    Financial Health
    Debt/Equity0.08xInterest CoverageN/A
    Current Ratio5.33xQuick Ratio4.79x
    Trading Statistics
    Beta1.17Avg Volume1.12M
    52-Week High$7.9752-Week Low$3.03

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.65
    SMA 20$4.70
    SMA 50$4.53
    SMA 200$4.42
    EMA 10$4.68
    EMA 20$4.66
    EMA 50$4.53
    EMA 200$4.68

    MACD

    Line: 0.04Signal: 0.04Hist: -0.01

    ADX

    ADX: 16.5+DI: 19.8-DI: 17.6

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down52.0
    PSAR$4.40

    Bollinger Bands

    Upper Band$4.88
    Lower Band$4.51
    %B Position773%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    53.5

    Momentum Oscillators

    Stoch %K60.1
    Stoch %D50.5
    Williams %R-38.3
    ROC (10d)0.4%
    Momentum0.02
    CCI (20d)56.3
    MFI (14d)26.5

    Volatility Measures

    ATR (14d)$0.17(3.6%)
    StdDev (20d)0.09
    Hist Vol25.6%(Moderate)

    Volume Flow

    VWAP$4.75
    OBV-519.0K
    AD Line-2.2M
    CMF (20d)0.285

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio0.9x
    VWMA (20d)$4.70

    Pivot Points

    R3$5.11
    R2$4.98
    R1$4.90
    Pivot Point$4.77
    S1$4.69
    S2$4.56
    S3$4.48

    Advanced Oscillators

    TSI9.26
    Ultimate Osc59.4
    KST27.96

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$64.36M$58.99M$118.09M$113.72M$98.61M$88.20M$92.91M$84.06M$87.21M$84.71M$86.83M$81.71M
    Cost of Revenue$19.98M$17.37M$19.05M$18.72M$18.68M$16.56M$16.91M$15.32M$14.86M$12.99M$13.84M$14.79M
    Gross Profit$44.38M$41.62M$99.04M$95.01M$79.92M$71.65M$76.00M$68.73M$72.35M$71.72M$72.99M$66.92M
    Operating Expenses$62.85M$57.67M$77.96M$72.82M$67.55M$63.40M$64.94M$57.57M$48.90M$58.52M$57.50M$55.80M
    R&D$2.78M$4.14M$4.76M$3.70M$3.30M$3.33M$3.57M$2.92M$3.01M$2.84M$2.43M$3.08M
    SG&A$59.78M$53.23M$73.07M$69.00M$64.15M$59.97M$61.04M$53.52M$55.40M$55.13M$54.35M$52.57M
    Operating Income$-18,466,000$-16,049,000$21.08M$22.19M$12.37M$8.25M$11.05M$11.16M$23.45M$13.20M$15.49M$11.12M
    Interest Income$788,000$886,000$904,000$785,000$738,000$506,000$403,000$278,000$3,000$-1,690,000$0$-1,680,000
    Interest Expense$0$0$0$0$0$0$0$0$234,000$1.79M$1.58M$1.69M
    Income Before Tax$-17,780,000$-15,331,000$21.79M$22.85M$13.01M$8.61M$11.25M$11.42M$23.22M$11.41M$13.91M$9.43M
    Income Tax Expense$-2,940,000$-4,471,000$6.61M$6.10M$3.39M$1.59M$3.81M$3.54M$5.59M$2.35M$-37,374,000$591,000
    Net Income$-14,840,000$-10,860,000$15.19M$16.75M$9.62M$7.02M$7.44M$8.10M$17.63M$9.26M$53.48M$8.53M
    EBITDA$-17,037,000$-14,600,000$24.11M$27.35M$15.44M$11.31M$13.84M$12.30M$24.36M$13.91M$16.88M$12.33M
    EBIT$-18,568,000$-16,217,000$20.89M$22.06M$12.27M$8.11M$10.85M$11.14M$23.21M$13.10M$15.51M$11.11M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MDXG

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Form 425 Sanara MedTech Inc. Filed by: MIMEDX GROUP, INC.

    MiMedx Group, Inc. has filed a Form 425 regarding its proposed merger with Sanara MedTech Inc. The filing indicates that both companies received a Second Request from the Federal Trade Commission (FTC) in connection...

    StreetInsider•10/16/26•Somewhat-Bearish

    MiMedx schedules October 28 results. Analysts set a USD 8.57 target for MiMedx stock

    MiMedx has scheduled its third-quarter results webcast for October 28, 2026, at 4:30 p.m. Eastern Time. The company's second-quarter revenue of $64.36 million exceeded estimates...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026

    MIMEDX Group, Inc. (Nasdaq: MDXG) announced it will report its third-quarter 2026 operating and financial results after market close on Wednesday, October 28...

    GlobeNewswire•10/14/26•Neutral

    MiMedx Group stock gained 1.54 percent on October 6

    MiMedx Group (MDXG) stock gained 1.54 percent on October 6, closing at USD 4.62 on Nasdaq. This increase followed a "Moderate Buy" consensus from seven analysts, who set an average 12-month price target of USD 8.57...

    AD HOC NEWS•10/6/26•Somewhat-Bullish

    Sanara MedTech Shareholders Approve Merger with MiMedx

    Sanara MedTech shareholders have approved a merger agreement under which it will become a wholly owned subsidiary of MiMedx Group Inc. The merger still requires regulatory review under the Hart-Scott-Rodino Act...

    The Globe and Mail•10/3/26•Somewhat-Bullish

    MDXG Valuation and Fair Value

    P/E
    24.7x
    Forward P/E
    19.5x
    EV/EBITDA
    29.0x
    P/FCF
    15.6x
    PEG
    2.9x
    P/B
    3.2x
    See GNG's fair value

    MDXG Profitability: Margins, ROIC and FCF

    Gross margin
    78.8%
    Operating margin
    -28.7%
    Net margin
    1.8%
    ROIC
    2.3%
    ROE
    2.9%
    FCF margin
    12.5%
    FCF yield
    6.4%

    MDXG Competitors

    CompanyTicker
    Gyre Therapeutics Inc.GYRE
    Design Therapeutics IncDSGN
    Annexon IncANNX
    Inventiva SaIVA
    Sana Biotechnology IncSANA
    4D Molecular Therapeutics IncFDMT
    Verastem IncVSTM
    Pharming Group NVPHAR

    Sector: Healthcare

    MDXG Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    MDXG Bull Case vs Bear Case

    Bull case

    • 100.0% of MDXG's analyst ratings are Buy or Strong Buy.

    Bear case

    • MDXG's quarterly revenue changed -34.7% year over year.

    MDXG Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    16.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About MDXG

    Does MDXG pay dividends?

    MiMedx Group Inc (MDXG) does not currently pay a regular dividend.

    What is MDXG's P/E ratio?

    MiMedx Group Inc has a price-to-earnings (P/E) ratio of 24.68.

    What is MDXG's market cap?

    MiMedx Group Inc (MDXG) has a market capitalization of $685.89M with a current stock price of $4.69.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In